TherapeuticsMD (TXMD) Current Assets (2010 - 2026)
TherapeuticsMD (TXMD) reported Current Assets of $16.12 million for Q2 2026, up 19.8% from $13.46 million a year earlier and up 5.6% from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, TherapeuticsMD posted Current Assets of $14.45 million, up 17.8% from FY2024.
- Current Assets has a five-year compound annual growth rate of -35.4% (FY2020 to FY2025).
- By year, Current Assets came in at $12.26 million in FY2024 (+3.9%), $11.8 million in FY2023 (-78.7%), $55.35 million in FY2022 (-53.7%) and $119.47 million in FY2021 (-7.0%).
- The Q2 2026 figure ranks as the highest quarterly Current Assets since Q3 2023.
- Year over year, Current Assets has now increased in each of the last seven quarters, with growth averaging 9.4% over the last eight quarters.
- The high point for year-over-year Current Assets in five years was Q3 2021 (growth of 30.7%); the low point was Q2 2023 (a decline of 80.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $15.26 million (Q1 2026), $14.45 million (Q4 2025) and $14.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - | 16.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.12 Mn |
| Mar 31, 2026 | 15.26 Mn |
| Dec 31, 2025 | 14.45 Mn |
| Sep 30, 2025 | 14.50 Mn |
| Jun 30, 2025 | 13.46 Mn |
| Mar 31, 2025 | 12.51 Mn |
| Dec 31, 2024 | 12.26 Mn |
| Sep 30, 2024 | 12.15 Mn |
| Jun 30, 2024 | 11.82 Mn |
| Mar 31, 2024 | 11.52 Mn |
| Dec 31, 2023 | 11.80 Mn |
| Sep 30, 2023 | 17.44 Mn |
| Jun 30, 2023 | 19.61 Mn |
| Mar 31, 2023 | 24.74 Mn |
| Dec 31, 2022 | 55.35 Mn |
| Sep 30, 2022 | 87.48 Mn |
| Jun 30, 2022 | 98.60 Mn |
| Mar 31, 2022 | 84.42 Mn |
| Dec 31, 2021 | 119.47 Mn |
| Sep 30, 2021 | 159.98 Mn |
API Access
TherapeuticsMD Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();